Pioneering quality control in biomanufacturing of cell and gene therapies
Lauren Coyle, Commissioning Editor, Cell & Gene Therapy Insights, speaks with Dhruv Sareen, Executive Director at Cedars-Sinai Biomanufacturing Center, and Johnathan Rodriguez, Quality Control Manager at Cedars-Sinai Biomanufacturing Center, about the roles of in-process controls, method validation, risk management, and automation in biomanufacturing. They will highlight strategies to ensure product safety, consistency, and regulatory compliance for cell and gene therapy products.
Institutions
- Cedars-Sinai Medical Center (US)
Publication Details
- Journal
- Cell and Gene Therapy Insights
- Published
- 2024-12-05
- DOI
- https://doi.org/10.18609/cgti.2024.178
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cedars-Sinai Medical Center